Greg E. Gardiner
Keine laufenden Positionen mehr
Profil
In addition to Elm Street, Dr. Gardiner serves as an advisor to Yale University’s Office of Cooperative Research (OCR), of which he was Managing Director for three years, and holds an adjunct faculty position at the Yale School of Medicine.
He is a director of four biotech companies, and a consultant and advisor to several investment funds and pharmaceutical and biotech companies.
As Managing Director of Yale’s OCR, he was responsible for commercial development of technology and licensing of intellectual property created by Yale faculty and bringing venture capital funding to companies in the New Haven area.
Prior to that, Dr. Gardiner was Group Director of R&D Operations, Pfizer Central Research, where he designed and implemented Pfizer’s external biotechnology strategy.
He also participated in the management of Pfizer’s worldwide drug discovery program, and was responsible for the scientific evaluation of licensing candidates including Lipitor, Celebrex, and Aricept.
Dr. Gardiner received a Ph.D.
in Physical Chemistry from Fordham University and was a Sterling Fellow in Chemistry at Yale.
Ehemalige bekannte Positionen von Greg E. Gardiner
| Unternehmen | Position | Ende |
|---|---|---|
Bionaut Pharmaceuticals, Inc.
 Bionaut Pharmaceuticals, Inc. BiotechnologyHealth Technology Bionaut Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. It is a Biotechnology company using its technology to discover and advance novel small molecule drug candidates that affect well-validated disease pathways. Bionaut's business strategy is to license its candidates at a late preclinical stage to pharmaceutical and large biotech companies for development. The company was founded in August, 2000 by Mehran M. Khodadoust & Thomas Klein and is headquartered at Cambridge, MA. | Vorsitzender | 26.11.2008 |
Idameneo (No. 789) Ltd.
 Idameneo (No. 789) Ltd. Pharmaceuticals: MajorHealth Technology Idameneo (No. 789) Ltd. provides diagnostic and wellness products and services. It offers services through its pathology, diagnostic imaging, medical centers, and pharmacy services divisions. The company is headquartered in St Leonards, Australia.. | Direktor/Vorstandsmitglied | 27.03.2008 |
Thetis Pharmaceuticals LLC
 Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Thetis Pharmaceuticals LLC is a biopharmaceutical company. It improves the lives of patients suffering from gastrointestinal diseases. The company’s proprietary HEALER™ technology platform enables the pharmaceutical development of bioactive lipids, including resolving and other fatty acids, that actively regulate inflammation resolution and tissue repair. Its technologies are pro-resolving lipids and intellectual property. The company was founded by Frank C. Sciavolino, Banavara L. Mylari and Gary Mathias in 2011 and is headquartered in Southport, CT. | Corporate Officer/Principal | - |
Elm Street Advisors LLC
 Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut. | Private Equity Investor | - |
Affomix Corp.
 Affomix Corp. Pharmaceuticals: MajorHealth Technology Affomix Corp. was develops and commercializes antibody based products. The company was founded in 2008 and headquartered in Branford, CT. | Direktor/Vorstandsmitglied | - |
Ausbildung von Greg E. Gardiner
| Fordham University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Affomix Corp.
Affomix Corp. Pharmaceuticals: MajorHealth Technology Affomix Corp. was develops and commercializes antibody based products. The company was founded in 2008 and headquartered in Branford, CT. | Health Technology |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Bionaut Pharmaceuticals, Inc.
Bionaut Pharmaceuticals, Inc. BiotechnologyHealth Technology Bionaut Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. It is a Biotechnology company using its technology to discover and advance novel small molecule drug candidates that affect well-validated disease pathways. Bionaut's business strategy is to license its candidates at a late preclinical stage to pharmaceutical and large biotech companies for development. The company was founded in August, 2000 by Mehran M. Khodadoust & Thomas Klein and is headquartered at Cambridge, MA. | Health Technology |
Idameneo (No. 789) Ltd.
Idameneo (No. 789) Ltd. Pharmaceuticals: MajorHealth Technology Idameneo (No. 789) Ltd. provides diagnostic and wellness products and services. It offers services through its pathology, diagnostic imaging, medical centers, and pharmacy services divisions. The company is headquartered in St Leonards, Australia.. | Health Technology |
HistoRx, Inc.
 HistoRx, Inc. Medical SpecialtiesHealth Technology HistoRx, Inc. develops tissue-based diagnostic products. The company was founded on July 23, 2004 and is headquartered in Carlsbad, CA. | Health Technology |
Elm Street Advisors LLC
Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut. | Finance |
Thetis Pharmaceuticals LLC
Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Thetis Pharmaceuticals LLC is a biopharmaceutical company. It improves the lives of patients suffering from gastrointestinal diseases. The company’s proprietary HEALER™ technology platform enables the pharmaceutical development of bioactive lipids, including resolving and other fatty acids, that actively regulate inflammation resolution and tissue repair. Its technologies are pro-resolving lipids and intellectual property. The company was founded by Frank C. Sciavolino, Banavara L. Mylari and Gary Mathias in 2011 and is headquartered in Southport, CT. | Health Technology |
